Anonymous ID: add159 Aug. 1, 2023, 9:33 p.m. No.19283200   🗄️.is đź”—kun

>>19282984

Court documents reveal more details about 2017 homicides of Barry and Honey Sherman

Social Sharing

No arrests, but search warrant documents reveal additional details of 2017 deaths of Barry and Honey Sherman

John Lancaster · CBC News · Posted: Jan 05, 2021 4:00 AM EST | Last Updated: June 12, 2021

 

Barry Sherman, 75, the founder and chairman of the board of generic drug giant Apotex, and his 70-year-old wife, Honey, were found dead in the basement pool area of their home on Old Colony Rd. in Toronto's North York neighborhood on Dec. 15, 2017.

 

In the weeks leading up to their deaths, Apotex lost a $500 million court case involving a drug patent. It had also just laid off numerous staff, and more cuts were coming.

 

While the information piqued the interest of investigators, Barry Sherman's long-time business partner Jack Kay told them it likely had nothing to do with the couple's deaths.

 

https://www.cbc.ca/news/canada/toronto/barry-honey-sherman-murder-2021-1.5860527

 

Barry Sherman’s company says fired employee stole valuable drug secrets

 

A lawsuit filed by Apotex months before the murders of Barry and Honey Sherman alleges the worker planned to start his own drug-making company

 

By Michael Friscolanti and Anne Kingston March 6, 2018

 

Apotex Inc., the generic-drug giant founded by murdered billionaire Barry Sherman, has been waging a year-long court battle against an ex-employee who was fired for allegedly stealing millions of dollars’ worth of pharmaceutical trade secrets from a laboratory computer—in the hopes of launching a rival company in his native Pakistan.

 

https://macleans.ca/news/canada/apotex-claims-longtime-chemist-went-rogue-and-stole-drug-secrets/

 

The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls

By Kyle Blankenship

Jul 10, 2019 12:08pm

 

https://www.fiercepharma.com/pharma/apotex-loses-31-generic-approvals-after-fda-cites-manufacturing-deficiencies-at-2-plants